Jnc 7 Adv Day1 Set2 Mmd Beal Htn

Embed Size (px)

Citation preview

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    1/21

    Hypertension JNC 7 Guidelines

    The Seventh Report of theJoint National Committee on Prevention

    www.nhlbi.nih.gov/guidelines/hypertension

    Jeffrey Beal, M.D.

    Clinical Director, Florida/CaribbeanAIDS Education and Training Center

    AAHIVMS

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    2/21

    Disclosure of Financial Relationships

    Speakers Bureau: Bristol-Myers Squibb, Glaxo

    This slide set has been peer-reviewed to ensure that there are no conflicts of

    interest represented in the presentation.

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    3/21

    All of the following are key

    messages from JNC 7 except:1. Systolic BP > 140 mmHG is a much more

    important CVD risk factor than diastolic BP in

    persons >50 y/o2. The risk of CVD beginning at 115/75 mmHg

    doubles with each increment of 20/10 mmHg

    3. Thiazide-type diuretics are rarely indicated in

    the treatment of hypertension4. Goal blood pressure for hypertensive patients

    is

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    4/21

    Which of the following is incorrect for the

    proper measurement of BP in the officesetting?

    1. Persons should be seated for at least 5

    minutes resting before taking the BP

    2. BP should be taken with the patient sitting onexam table with the arm relaxed in their lap

    3. At least 2 measurements should be made

    4. SBP is the point at which the first of two ormore sounds is heard

    5. DBP is the point before the disappearance of

    sound (phase 5)

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    5/21

    Normal blood pressure is

    defined in JNC 7 as:1.

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    6/21

    JNC 7 Classification of BP1. Normal BP = < 120/80

    2. Prehypertension = 120-139/80-893. Stage 1 HTN = 140-159/90-99

    4. Stage 2 HTN = 160/100

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    7/21

    Of the following lifestyle modifications, which

    has the greatest potential reduction in SBP?

    1. Weight loss to normal body weight (BMI

    18.5-24.9 kg/m2)

    2. Adopting the DASH eating plan

    3. Dietary sodium restriction

    4. Physical activity5. Moderation of alcohol intake

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    8/21

    Recommendation SBP Reduction

    Maintain normal body weight

    (BMI 18.5-24.9 kg/m2)

    5-20 mmHg/10 kg weight

    loss

    Diet rich in fruits, vegetables,

    & fat dairy products with

    reduced saturated and total fat

    8-14 mmHg

    Sodium to

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    9/21

    Management of Hypertension 60 y/o HIV positive Black female has initial

    and 3 subsequent office visits with

    elevated BP by nurse Blood pressure 140/96, repeated 5

    minutes later 142/92

    Patient assessed as Stage 1 HTN

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    10/21

    CV Risk Factors HTN

    Cigarette Smoking Obesity: Weight 220lbs, height 56 = BMI35.5

    Physically Inactive Dyslipidemia: Chol, HDL, Nl LDL/Trig.

    Diabetes mellitus

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    11/21

    CV Risk Factors Microalb. or Estimated GFR 55 for, > 65 FH premature CV disease (

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    12/21

    Physical Exam BP equivalent in both arms

    Grade II KW changes on funduscopic Waist circumference >40 , >35 (pt.42)

    No carotid, abdominal, femoral bruit

    Nl thyroid palpation, heart, lung andabdomen exam, lower ext. pulses, and

    neurologic exam

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    13/21

    Lab/other diagnostic ECG mild LVH

    UA, Glucose, Hct., serum K+

    , Creatinine,Ca++, Triglycerides normal

    Chol. 230 mg/dL, HDL 30 mg/dL, LDL 88mg/dL

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    14/21

    Identifiable Causes of HTN Sleep apnea

    CKD

    Primary aldosteronism (K+, fails HTN tx.) Renovascular ds.

    Chronic steroids/Cushings syndrome

    Pheochromocytoma Coarctation of aorta

    Thyroid/Parathyroid disease

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    15/21

    Medications Causing HTN NSAID, especially Cox-2 inhibitors Cocaine, amphetamine, other illicit drugs

    Sympathomimetics (decongestants, anorectics) Oral contraceptives Adrenal steroids Cyclosporine and tacrolimus

    Erythropoietin Licorice (including some chewing tobacco) OTC (ephedra, ma haung, bitter orange)

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    16/21

    Lifestyle Modification Lifestyle modification education done

    Weight loss and exercise

    Low Na++, DASH diet

    Low fat diet

    Patient never drinks more than 4 oz. wine,2-3 meals per week

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    17/21

    Patient Concomitant Medication Atazanavir 300 mg + Ritonavir 100 mg +

    Truvada

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    18/21

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    19/21

    What medication(s) would you

    start?1. Diuretic therapy

    2. ACE Inhibitor3. Angiotensin receptor blocker

    4. Beta-blocker

    5. Calcium channel blocker6. Diuretic plus one of the above

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    20/21

    Generalizations for HTN/HIV No clinical studies to date with ARV

    therapy and pharmacologic effect on

    antihypertensive medications

    Best to start with one drug and add usinglowest starting dose and increasing on at

    least monthly visits if patient clinicallystable

  • 7/31/2019 Jnc 7 Adv Day1 Set2 Mmd Beal Htn

    21/21

    Antihypertensive Drugs Diuretics: no drug interactions

    Beta Blockers:

    Monitor prolonged PR interval ATV Ritonavir can increase BB levels

    NNRTI can BB levels

    ACE inhibitors and ARB

    Varied effect

    Calcium Channel Blockers In general levels increased